Talking Medicines
PrivateLast Round
Convertible Debt
May 26, 2026
Est. Valuation
$10.15M
Total Funding Raised
$5.13M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Talking Medicines is a healthtech company that provides a healthcare technology tool designed to capture, curate, and structure the voice of the patient on launched medicines.
Sector
Healthcare & Life Sciences
Verticals
Healthcare Analytics, NLP & Conversational AI, Patient Engagement, Medical AI, Marketing
Business Model
B2B
Customer Profile
Subscription SaaS, Data as a Service
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Talking Medicines Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Talking Medicines Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Convertible Debt | May 26, 2026 | ||||
| Convertible Debt | Feb 1, 2024 | ||||
| Seed | Feb 1, 2022 | ||||
| Seed | Nov 5, 2020 | ||||
| Seed | May 13, 2019 | ||||
Grant | Aug 28, 2017 |
Key People
Founding team and executive leadership
Talking Medicines Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Tern PLC | Seed, Convertible Debt |
| Social Investment Scotland (SIS) Ventures | Seed, Convertible Debt |
| Scottish Investment Bank (Scottish Enterprise) | Seed, Convertible Debt |
| SIS Ventures | Seed, Convertible Debt |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 26, 2026
$65K round raised with Tern PLC
- Jan 8, 2026
Included in Top 1,000 UK AI Companies list.
Talking Medicines Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Talking Medicines's valuation, stock price, and market status.